# S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

> **NCT00004124** · PHASE3 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 983 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** bicalutamide
- **DRUG:** goserelin
- **DRUG:** mitoxantrone hydrochloride
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00004124
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10-15
- **Primary completion:** 2017-08-12
- **Final completion:** 2018-05-01
- **Target enrollment:** 983 (ACTUAL)
- **Last updated:** 2022-12-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004124, "S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00004124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*